The Edinburgh Investment Trust plc Issues Warning From Woodford

The portfolio manager of the Edinburgh Investment Trust plc (LON: EDIN), Neil Woodford, sees lower returns during the next three years.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The shares of Edinburgh Investment Trust (LSE: EDIN) climbed 7p to 585p during early trade this morning despite the FTSE 250 member publishing half-year results that carried a warning from Neil Woodford.

Mr Woodford, who manages the portfolio owned by the Edinburgh trust through investment group Invesco Perpetual, cautioned that “returns over the next three years are likely to be somewhat lower than over the last three years, purely as a consequence of the higher valuations that we now see in our market.

He also claimed the withdrawal of “extraordinary” monetary policies in the US was “ultimately inevitable” and admitted he was worried about “the near-term implications of tapering” for equities.

While Mr Woodford added it was “more difficult than usual” to predict the path that the market could take over the next few months, he did reassure shareholders of the Edinburgh trust that their portfolio had “the potential to deliver an attractive positive return over more sensible, longer-time horizons.”

The trust’s half-year results showed the portfolio’s net assets advancing 2% to 592p per share with debt measured at par value.

Major holdings at the September half-year included Woodford favourites GlaxoSmithKline, AstraZeneca, BT, British American Tobacco and Roche.

Mr Woodford also took the opportunity to criticise recent political remarks about the utility sector.

Referring to the 20-month bill freeze proposed by the Labour Party, he described the economics of the policy as “absurd“.

Mr Woodford claimed:

We believe it is irrational for any privately-owned company to sell its products or services at a loss and we would encourage any company that was forced to do so to simply stop supplying.

Prices have not increased through company profiteering – there have been 20 separate inquiries into the energy market since 2001, none of which have found evidence of anti-competitive behaviour.

The Edinburgh trust has stakes in gas supplier Centrica and electricity generator SSE.

Last month Mr Woodford announced he would leave Invesco Perpetual in April to start his own fund-management business.

Jim Pettigrew, the chairman of the Edinburgh trust, said the board “would like to take some time to consider the options for the future management of the company before it makes a decision“.

Based on this morning’s share-price reaction, Edinburgh’s shares trade at about book value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Maynard does not own any share mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Growth Shares

Could dirt cheap Volex be one of the best UK stocks to buy today?

When looking for stocks to buy, it can pay to seek out long-term growth potential at a reasonable price. One…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 50% in 5 years, this is the FTSE 250 stock I want to buy now

Think the FTSE 100 is the only place to find top value dividend stocks? I think this FTSE 250 stock…

Read more »

Investing Articles

What will a general election mean for the UK stock market?

The Prime Minister must hold an election before 28 January 2025. Our writer considers what the consequences might be for…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

£20,000 in savings? Here’s how I’d aim to turn that into a £1,231 monthly second income!

Generating a sizeable second income can be life-enhancing, and it can be done from relatively small investments in high-dividend-paying stocks.

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

I don’t care how much FTSE bosses are paid as long as they make me rich!

Facing accusations of greed, the pay packages of FTSE CEOs are back in the headlines. But our writer takes a…

Read more »

woman sitting in wheelchair at the table and looking at computer monitor while talking on mobile phone and drinking coffee at home
Investing Articles

Is the Lloyds share price overvalued right now?

This Fool has loved watching the Lloyds share price climb higher in 2024. Here are three good reasons why I’m…

Read more »

Investing Articles

Everyone’s talking about Tesla shares. Should I buy?

Jon Smith explains why the price of Tesla shares has been falling fast, but flags up the imminent results release…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Is Legal & General’s share price the best bargain in the FTSE 100?

Legal & General’s share price looks very undervalued to me. It also yields 8.3% and seems set to benefit from…

Read more »